View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

[link removed]

**The Latest Research, Commentary, and News from Health Affairs**

**Thursday, August 8, 2019**

TODAY ON THE BLOG

ACCESS TO CARE

Who Will Be Our Moral Conscience Now? A Tribute To Uwe Reinhardt

By Janet Currie, Katherine Ho, B. Rose Kelly, and Ilyana Kuziemko

One thing that most people can agree on is that everyone, regardless of
income or socioeconomic status, should have access to necessary care. We
can honor Uwe's legacy by keeping this mantra forever at the forefront
of our work. Read More >>

PHARMACEUTICALS & MEDICAL TECHNOLOGY

The Economics Of Biologic Drugs: A Further Response To Bach et al.

By Alex Brill and Benedic Ippolito

We begin by commenting on expectations for biologic prices in a market
with biosimilar competition before responding to some of Bach et al.'s
new arguments and explaining why we remain steadfast that biologic drugs
as a group are not natural monopolies, that the early evidence from
biosimilar entry is encouraging, and that a host of policy options other
than price controls can be considered to lower costs within this market.
Read More >>

WORKFORCE IN THE COMMUNITY

Leveraging Technology To Support-Not Supplant-The Home Care
Workforce

By Kezia Scales

To mitigate potential risks when introducing new technologies in home
care, it is essential to involve consumers and workers in every stage of
the research and development process. Read More >>

ADOLESCENTS

The Forgotten Billion In Universal Health Coverage And Three Ways To
Make Them A Priority

By Stefan Germann

The CEO of Fondation Botnar, a funder based in Switzerland, cites
research showing that between 2003 and 2015, just 1.6 percent of global
health aid was targeted to specific health issues affecting young
people. If we are to truly realize universal coverage and achieve health
equity, we can no longer ignore this funding neglect. He urges all to
commit to three measures, including investment in new technologies, to
bring young people's health issues to the forefront. Read More >>

IN THE JOURNAL

MILITARY HEALTH SYSTEM
Readiness Of Medical Providers In The Military Health System: Overview
Of Operational And Policy Considerations

By Paul J. Hutter, Joachim Roski, Jonathan Woodson, Allen Middleton,
Robert Kneeland, Averston Worthy, Derik Zitelman, Thomas Trinh, Shaun
Dela Cruz, and Elaine Cooper

An essential component of the MHS is its ability to deploy medical
personnel on a moment's notice to remote, often austere, settings.
Paul Hutter and coauthors describe the challenge of gaining and
maintaining the skills necessary to treat battlefield wounds when most
training and medical practice occurs in traditional clinical settings,
where patients generally are treated for fairly routine conditions.Read
More >>

GOVERNMENT PROGRAMS & POLICIES

Veterans Health Administration Investments In Primary Care And Mental
Health Integration Improved Care Access

By Lucinda B. Leung, Lisa V. Rubenstein, Jean Yoon, Edward P. Post, Erin
Jaske, Kenneth B. Wells, and Ranak B. Trivedi

Lucinda Leung and coauthors report on results from the national Primary
Care-Mental Health Integration initiative of the Veterans Health
Administration, which embedded specialists, care managers, or both in
primary care clinics to care for veterans with psychiatric illness.
Read More >>

The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed

By Amanda M. Midboe, Thomas Byrne, David Smelson, Guneet Jasuja, Keith
McInnes, and Lara K. Troszak

Amanda Midboe and coauthors report on a retrospective observational
study to examine opioid use disorder in a national sample of veterans
who accessed specialized homeless programs in the Veterans Health
Administration. Read More >>

Read the August 2019 Table of Contents
on Military Health
Systems

****

****

Subscribe to Health Affairs

**for full journal access**

**A CLOSER LOOK**-Marijuana

The Drug Enforcement Agency announced that it has not approved more
applications for marijuana research, despite the increased popularity of
products with cannabidiol (CBD). A Health Affairs Blog post from last
year discussed the likelihood of the FDArescheduling marijuana

after the approval of Epidiolex, a drug that contains CBD.

[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs Today
, and Health Affairs Sunday
Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I